Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Allergy. 2019 May 30;74(10):1989–1991. doi: 10.1111/all.13825

The Impact of Prescribed Fire versus Wildfire on the Immune and Cardiovascular Systems of Children

Mary Prunicki 1, Rodd Kelsey 2, Justin Lee 1, Xiaoying Zhou 1, Edward Smith 2, Francois Haddad 1, Joseph Wu 1, Kari Nadeau 1
PMCID: PMC6801011  NIHMSID: NIHMS1024236  PMID: 31002401

To the Editor:

The increase in wildfires associated with climate change augments the impact of air pollution on health in many areas of the country. When wildfires occur, there is an increase in asthma attacks and associated co-morbidities,1,2 especially for asthma hospitalization in ages 0 to 5 years3 and more recently it has been shown that there are increases in cardiovascular events4. Given the health risks associated with high intensity wildfires, there is motivation to increase the use of lower intensity prescribed fires. Prescribed burns decrease the build-up of flammable vegetation and subsequent fuel for wildfires, mitigating the spread and intensity of wildfires. However, prescribed fire raises public concerns because of the additional pollutant exposure.

Therefore, our objective is to determine whether there are differential health consequences with a prescribed fire vs wildfire. We focus on children given their reduced lung size, increased metabolic rates, higher respiratory rate and developing immune systems5, and because in macaque monkeys who are exposed to wildfire smoke in infancy, there is associated immune dysregulation and decreased lung function in adolescence6. We hypothesize that the health impacts of a prescribed fire are less detrimental to the respiratory and cardiovascular systems than a wildfire in school-aged children and that T cell skewing and epigenetic modulation will occur with exposure to wildfire more than from exposure to a prescribed fire.

We analyzed data collected from a convenience sample of subjects (n=220) over a period of 2 years living in Fresno, CA, all of whom were potentially exposed to smoke from fires, which consisted of similar varieties of coniferous tress, in nearby Yosemite National Park. Health questionnaires, blood samples, and vital signs were collected and subjects were selected that had their blood drawn 3 months after a prescribed burn or wildfire, because our prior research indicates that this time frame is associated with increased methylation of the Foxp3 gene7. Using this criteria, we analyzed data from 32 children (median age=7 [range 7;8]yrs, 38% asthmatic as per NHLBI guidelines) exposed to a prescribed burn 70 miles away covering 553 acres in March, 2015, and 36 children (median age=8 [range 7;8]yrs, 25% asthmatic) exposed to a wildfire 70 miles away covering 415 acres in September, 2015. A control group of 18 children was also compared (median age=8 [range 7,8]yrs; 21% asthmatic), who had no obvious exposure to wildfires or prescribed burns and were living in the San Francisco Bay area, where pollution levels are consistently low (i.e. less than 10 ug/m3 of PM2.5). All subjects were consented with an IRB-approved protocol.

Pollution exposure was measured from 4 central site monitors and both distance-weighted to the subject’s home as in previous studies8 and averaged across the monitoring sites. Peripheral blood mononuclear cells were stained with metal-conjugated antibodies for surface markers and CyTOF was performed. Methylation studies using pyrosequencing were performed per published methods6 on selected CpG sites of the Foxp3, IL-4, IL-10 and IFNγ genes.

As shown in Figure 1, all pollutant levels were higher in the wildfire group (n=36) than the prescribed burn (n=32) groups (p<.0001; wildfire vs prescribed means: NO2=10.7 ppb ±0.3 vs 4.0 ppb ±0.2; NOx=25.6 ppb ±1.0 vs 9.9 ppb ±0.5; PAH456=11.4 ng/m3 ±0.4 vs 5.3 ng/m3 ±0.2; EC=1.0 ug/m3 ±0.02 vs 0.48 ug/m3 ±0.01; CO=.56 ppm ±0.02 vs .25 ppm ±0.01; PM10=41.5 ug/m3 ±1.1 vs 28.0 ug/m3 ±0.3; PM2.5=15.9 ug/m3 ±0.4 vs 10.0 ug/m3 ±0.2). In addition, average PM2.5 levels were calculated 2 weeks prior to each fire, throughout each fire and 2 weeks after each fire to determine the potential contributions of each fire. PM2.5 levels increased during the wildfire and then returned to baseline indicating that the wildfire was likely associated with the rise in PM2.5 levels (2 weeks prior mean=9.3 ug/m3 [SD=2.5]; during fire mean=13.7 ug/m3 [SD=5.7] vs 2 weeks after mean=9.1 ug/m3 [SD=1.9]). For the prescribed fire, the PM2.5 levels decreased 12 ug/m3 from pre to post fire, indicating that the prescribed burn likely did not contribute substantially to PM2.5 levels (2 weeks prior mean=17.8 ug/m3 [SD=5.9]; duration of fire mean=8.5 ug/m3 [SD=3.5]; 2 weeks post mean=5.8 ug/m3 [SD=2.4]).

Figure 1:

Figure 1:

Average levels of pollutants during the wildfire and prescribed fire. When comparing prescribed vs wildfire, p<.0001 for each pollutant shown.

To investigate the immune system, immunophenotype results were compared with a one-way ANOVA across the 3 groups for percent Th1 cells (CD4+, CXCR3+, CCR5+), revealing signicant differences among groups (p<.0001) as shown in Figure 2, with the lowest Th1% for the wildfire group (control 5.19% ±1.89; prescribed fire 3.99% ±0.34; wildfire 2.04% ±0.31). There were no significant differences between the groups for other immune cell types such as Th2 cells (CD4+, CCR4+, CCR6-; p=0.14) or T regulatory cells (CD4+, CD 25+, CD 127-;p=0.66).

Figure 2:

Figure 2:

Th1 Cell percentage of CD 4+ cells for children 90 days after being exposed to a prescribed fire, wildfire or no exposure (1-way ANOVA, p<.0001).

Methylation levels between the prescribed and wildfire groups were compared using linear regression models while controlling for covariates (age, sex, BMI percentile, race, second-hand smoke and asthma status). Foxp3 methylation in the promoter region of DNA isolated from the same blood samples was increased post wildfire exposure compared to prescribed fire exposure (B estimate (est)=2.59; Standard Error (SE)=0.95; p=0.01). Moreover, there was a trend toward worsened health outcomes in the wildfire group compared to the prescribed group, including increases in wheezing episodes in those with no prior history of asthma, increases in asthma exacerbations in those with prior asthma, and rises in pulse pressure (est=4.08;SE=2.35;p=0.09).

The increase in Foxp3 methylation associated with the wildfire is consistent with prior air pollution studies7,8. The reduction in Th1 pro-inflammatory T cells associated with wildfire exposure may be consistent with the molecular heterogeneity of asthma and associated endotypes9. Moreover, in cardiovascular disease, which is an inflammatory process and also associated with air pollution and wildfires, Th1 cells have been associated with immunity in atherosclerosis10. While this is a descriptive, retrospective study and the PM levels do not distinguish from various sources including fires, these preliminary results suggest future studies are needed. This will allow us to both understand the mechanism by which wildfire exposure impacts the immune system and to investigate the health impact of prescribed fire versus wildfire, as there is heightened motivation to increase the application of prescribed burns to combat the risks of increasing wildfire size and intensity in several areas of the country.

Funding Sources:

The Nature Conservancy, NIEHS, NHLBI, and Sean N Parker Center for Allergy and Asthma Research at Stanford University.

Conflict of Interest: Dr. Kari Nadeau indicates that she has received funding, is currently funded by, or has cofounded the following: National Institutes of Health (NIH), Food Allergy Research & Education (FARE), End Allergies Together (EAT), Before Brands, Alladapt Immunotherapeutics, Adare Pharmaceuticals, AstraZeneca, Novartis, Genentech, Astellas, DBV Technologies, ForTra, Aimmune Therapeutics, Regeneron, Sanofi, Nestle, and the Environmental Protection Agency (EPA).

References

  • 1.D’Amato G et al. Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization. WAO J 2015; 8(1): 34–37 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Reid CE, Brauer M, Johnston FH, Jerrett M, Balmes JR, Elliott CT. Critical Review of Health Impacts of Wildfire Smoke Exposure. Environ Health Perspect 2016;124: 1334–1343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Delfino RJ, Brummel S, Wu J, et al. The relationship of respiratory and cardiovascular hospital admissions to the southern California wildfires of 2003. Occup Environ Med 2009;66: 189–197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wettstein ZS, Hoshiko S, Fahimi J, Harrison RJ, Cascio WE, Rappold AG. Cardiovascular and Cerebrovascular Emergency Department Visits Associated With Wildfire Smoke Exposure in California in 2015. J Am Heart Assoc 2018;11;7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Perera FP, Rauh V, Whyatt RM, et al. Effect of prenatal exposure to airborne polycyclic aromatic hydrocarbons on neurodevelopment in the first 3 years of life among inner-city children. Environ Health Perspect 2006;114: 1287–1292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Black C, Gerriets J, Fontaine J et al. Early Life Wildfire Smoke Exposure Is Associated with Immune Dysregulation and Lung Function Decrements in Adolescence. Am J Respir Cell Mol Biol 2017; 56: 657–666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Prunicki M, Stell L, Dinakarpandian D, et al. Exposure to NO2, CO, and PM2.5 is linked to regional DNA methylation differences in asthma. Clin Epigenetics 2018; 10: 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Nadeau K, McDonald-Hyman C, Noth E, et al. Ambient Air Pollution Impairs Regulatory T-cell Function in Asthma. J Allergy Clin Immunol 2010; 126: 845–852. [DOI] [PubMed] [Google Scholar]
  • 9.Fahy JV. Type 2 inflammation in asthma--present in most, absent in many. Nat Rev Immunol 2015;15; 57–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Olson NC, Sallam R, Doyle MF, Tracy RP, Huber SA. T helper cell polarization in healthy people: implications for cardiovascular disease. J Cardiovasc Transl Res 2013; 6: 772–786. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES